Eximis Surgical develops a fully contained device that enables surgeons to remove large specimens through small incisions, enhancing the practice of minimally invasive surgery. This technology reduces incision sizes from up to 7 cm to significantly smaller openings, resulting in less postoperative pain and shorter hospital stays for approximately 2 million patients annually.
Funding
$15.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
QCFounders
Product
Problem
Many minimally invasive surgeries still require larger incisions (up to 7cm) at the end of the procedure for specimen removal, negating some of the benefits of the minimally invasive approach. This can lead to increased post-operative pain, longer hospital stays, and delayed return to normal activities for patients.
Solution
Eximis Surgical is developing a fully contained device designed to enable surgeons to remove large specimens through significantly smaller incisions during minimally invasive surgery. This technology aims to maintain the benefits of minimally invasive techniques throughout the entire procedure, from start to finish. By reducing the size of the incision needed for specimen removal, the device intends to minimize post-operative pain and shorten hospital stays, allowing patients to recover faster and return to their normal routines sooner. The device offers a fast, easy, and safe solution for specimen extraction.
Target Audience
The primary target audience includes surgeons performing minimally invasive procedures, particularly those in gynecologic oncology and general surgery, as well as patients seeking less invasive surgical options.
Features
- Fully contained system for specimen removal.
- Designed for use in a variety of minimally invasive surgical procedures.
- Aims to reduce incision size compared to traditional specimen removal methods.